Aurora Cannabis (ACB) earnings

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $276M

In the quarter ended March 2025, Aurora Cannabis had revenue of —.

On August 5, 2026 it reported EPS of 0.04 against an estimate of -0.13 (beat).

The next report is expected on Wednesday, November 4, 2026, with EPS expected around -0.03.

Report dates

ReportDateTimeEPS estimateEPS reported
NextWed Nov 4, 2026 — -0.03 —
LastWed Aug 5, 2026 — -0.13 0.04

Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.

Quarterly results

The last 5 quarters from Aurora Cannabis's 10-Q and 10-K filings with the SEC, in CAD. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.

Quarter endedRevenueGrowthEPS (diluted)GrowthOp. marginFiled
Mar 31, 2025— — — — — 2025-06-18
Dec 31, 2024— — — — — 2025-06-18
Sep 30, 2024— — — — — 2025-06-18
Jun 30, 2024— — 0.10 — — 2025-06-18
Jun 30, 2022— — — — — 2022-09-21
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ACB.
Open ACB in Investingly

Questions

When does Aurora Cannabis report earnings?

Aurora Cannabis's next earnings report is expected on November 4, 2026.

How did Aurora Cannabis do last quarter?

In the quarter ended March 2025, Aurora Cannabis had revenue of —.

From Aurora Cannabis's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.